Ann: Mesoblast Resubmits BLA with FDA for Ryoncil Approval, page-230

First 230 Last

Share
Profile

Follow
Grainger

208 Posts.

101

12/07/24

08:56

Post #: 74719478
Share

Originally posted by JB1975: ↑

I saw the same article - same author - in the Herald Sun and The Australian. That was the author I emailed. Before emailing him (and someone else did as well) I googled to see if he was maybe a rookie - he wasn't. In the brief search on his name I found probably a linked in summary that if I recalled correctly stressed his interest in integrity in markets or something similar so, although I didn't mention I'd seen that, I sort of hoped to get a reply even it was only to the effect that - yes I recorded Silviu that's what he said or perhaps no. I'm treating the non reply as either he doesn't want to make Silviu look bad - which he wouldn't at all if he'd quoted him accurately, or that the reporter isn't supper confident that what he put in quotes for Silviu is actually exactly what the FDA said either.

John Maynard Keynes said - when the facts change I change my mind - what do you do? I thought that a good line - but I think the answer for most people is just as pertinent - what most people actually do when the facts change and they are in conversation is (from a cognitive dissonance standpoint) they change the subject (to buy time to process or out of embarasment) and talk about something else.

Here is the full text of the email I sent to Cameron England (perhaps you would have worded it differently - perhaps you might have been briefer - perhaps there's a reason for no reply), Somebody else sent an email as well.

(quote)

Hello Cameron

As a small retail shareholder of a similar company and an ardent follower of Mesoblast's fortunes for the past years I read with much interest your article "US Food and Drug Administration acceptance of Mesoblast data bodes well for growth" in which Mesoblast CEO Silviu Itescu was quoted.

You wrote -

Mesoblast was asked for additional data, and went back to the FDA in January expecting to be told what more need to be done on the study front. (That is not in quotes).

Then

"And instead, what they said was 'no, we've thought this through, and you've convinced us that the clinical data are very strong," Prof Itescu said.

"You've got enough to get approval for children - go ahead and file, and then consider how to take the product into adults". Would you please confirm that that is a correct quote rather than that you or an editor may have altered it somewhat for brevity or by mistake?

Did you make a recording for instance?

I ask respectfully because I understand that mistakes can occur in good faith but the substance of what Silviu is saying to me reads like he is reporting events involving himself and the FDA in a way that is pithy and makes for good copy but does not seem to me to be how the FDA would speak.

Regards

JB (unquote)

Expand

Murdoch and journalistic standards are mutually exclusive. Have you ever looked at a Sky news headline? They literally manufacture what they report.

MSB Price at posting: $1.11 Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

ASX

ASX explains: How 'futures' are predicted

TAT

Tartana Minerals firms up producer status with recent 150tn shipment of copper sulphate to the NT

Is the ASX getting its groove back? Here's 5 IPOs in September to watch

RDN

Raiden Resources jumps 11% as Andover South drilling to kick off with PoW on Minister's desk

GMD

Genesis set for higher gold production in FY25 and earlier mill start

There are more pages in this discussion • 36 more messages in this thread...

First 230 Last

Add MSB (ASX) to my watchlist

(20min delay)
Last $1.06		Change 0.030(2.91%)		Mkt cap ! $1.210B

Open	High	Low	Value	Volume
$1.05	$1.09	$1.03	$5.796M	5.430M

Buyers (Bids)

No.	Vol.	Price($)
2	15990	$1.06

Sellers (Offers)

Price($)	Vol.	No.
$1.08	48632	3

View Market Depth

No.	Vol.	Price($)
2	15990	1.060
3	33766	1.055
2	38526	1.050
4	79050	1.045
3	54455	1.040

Price($)	Vol.	No.
1.075	48632	3
1.080	108135	6
1.085	103276	9
1.090	239204	9
1.095	74283	8

Last trade - 16.10pm 02/09/2024 (20 minute delay)

MSB (ASX) Chart

Ann: Mesoblast Resubmits BLA with FDA for Ryoncil Approval, page-230

ASX explains: How 'futures' are predicted

Tartana Minerals firms up producer status with recent 150tn shipment of copper sulphate to the NT

Is the ASX getting its groove back? Here's 5 IPOs in September to watch

Raiden Resources jumps 11% as Andover South drilling to kick off with PoW on Minister's desk

Genesis set for higher gold production in FY25 and earlier mill start

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Mesoblast Resubmits BLA with FDA for Ryoncil Approval, page-230

Top Stories

ASX explains: How 'futures' are predicted

Tartana Minerals firms up producer status with recent 150tn shipment of copper sulphate to the NT

Is the ASX getting its groove back? Here's 5 IPOs in September to watch

Raiden Resources jumps 11% as Andover South drilling to kick off with PoW on Minister's desk

Genesis set for higher gold production in FY25 and earlier mill start

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News